Xtalks Life Science Podcast
Targeting Ischemic Disease with DiaMedica CEO Rick Pauls
May 6, 202629 min
Show notes
In this week’s episode of the Xtalks Life Science Podcast, host Ayesha Rashid, Senior Life Science Journalist at Xtalks, spoke Rick Pauls, President and CEO of DiaMedica Therapeutics (Nasdaq: DMAC), a company advancing multiple programs in challenging vascular conditions driven by ischemia, including preeclampsia (PE), fetal growth restriction (FGR) and acute ischemic stroke (AIS).
Transcript
Transcript not available for this episode yet.
More from Xtalks Life Science Podcast
Addressing Neonatal Brain Injury: HIE Treatment Development with ReAlta Life Sciences’ Dr. Kia Motesharei
Jul 24, 202633 min
Why Endometriosis Needs New Treatment Approaches with EndoCyclic Therapeutics’ Dr. Tanya Petrossian
Jul 8, 202628 min
Precision Oncology in Lung Cancer with Boehringer Ingelheim’s Itziar Canamasas and Volker Teichgräber
Jun 24, 202625 min
Sustainability in Asthma and COPD Drug Development with Chiesi’s Diego Ardigò
Jun 10, 202624 min
What’s Next in Cardiometabolic Disease Drug Development: Obesity, MASH and Beyond with MetaVia’s Hyung Heon Kim
Jun 4, 202626 min